Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Placenta-expressed transcript 1 protein (PLET1) is a cell surface protein encoded by the PLET1 gene (also known as C11orf34) that is involved in processes such as cell migration, wound healing, cell-matrix adhesion, and trophoblast differentiation[3][7][1]. It exhibits a highly regulated expression pattern, being tightly repressed by DNA methylation in embryonic stem cells and expressed in trophoblast stem cells and certain differentiated cells[1][3]. PLET1 plays a critical role in balancing trophoblast self-renewal and differentiation, influencing lineage specification towards trophoblast giant cells or syncytiotrophoblast cells[1]. It is predicted to localize in the extracellular region and plasma membrane, and acts as a marker for progenitor/stem cell reservoirs[1][2][3][7]. Diseases associated with dysregulation of PLET1 include arthrogryposis multiplex congenita and DiGeorge syndrome; however, there are currently no known drugs targeting this protein[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Placenta-expressed transcript 1 protein (PLET1).